PDT Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,327
| Closed | -$205K | – | 680 |
|
|
2025
Q1 | $205K | Buy |
12,327
+1
| +0% | +$17 | 0.01% | 672 |
|
|
2024
Q4 | $226K | Sell |
12,326
-892
| -7% | -$16.4K | 0.02% | 635 |
|
|
2024
Q3 | $203K | Buy |
+13,218
| New | +$203K | 0.02% | 658 |
|
|
2024
Q1 | – | Sell |
-13,599
| Closed | -$426K | – | 617 |
|
|
2023
Q4 | $426K | Sell |
13,599
-27,160
| -67% | -$850K | 0.05% | 426 |
|
|
2023
Q3 | $849K | Sell |
40,759
-56,746
| -58% | -$1.18M | 0.11% | 323 |
|
|
2023
Q2 | $2.34M | Sell |
97,505
-69,490
| -42% | -$1.66M | 0.32% | 94 |
|
|
2023
Q1 | $3.14M | Buy |
166,995
+137,309
| +463% | +$2.58M | 0.43% | 63 |
|
|
2022
Q4 | $473K | Buy |
29,686
+6,400
| +27% | +$102K | 0.08% | 401 |
|
|
2022
Q3 | $381K | Sell |
23,286
-63,722
| -73% | -$1.04M | 0.06% | 513 |
|
|
2022
Q2 | $1.23M | Sell |
87,008
-157,817
| -64% | -$2.22M | 0.11% | 321 |
|
|
2022
Q1 | $5.93M | Buy |
244,825
+55,697
| +29% | +$1.35M | 0.51% | 17 |
|
|
2021
Q4 | $4.41M | Sell |
189,128
-34,002
| -15% | -$794K | 0.34% | 77 |
|
|
2021
Q3 | $3.71M | Buy |
223,130
+173,130
| +346% | +$2.88M | 0.27% | 175 |
|
|
2021
Q2 | $1.22M | Buy |
+50,000
| New | +$1.22M | 0.08% | 337 |
|
|
2018
Q4 | – | Sell |
-512,358
| Closed | -$10.6M | – | 458 |
|
|
2018
Q3 | $10.6M | Sell |
512,358
-169,142
| -25% | -$3.51M | 0.44% | 62 |
|
|
2018
Q2 | $10.4M | Buy |
681,500
+70,800
| +12% | +$1.08M | 0.4% | 79 |
|
|
2018
Q1 | $13.7M | Buy |
+610,700
| New | +$13.7M | 0.46% | 66 |
|
|
2016
Q1 | – | Sell |
-120,771
| Closed | -$4.31M | – | 557 |
|
|
2015
Q4 | $4.31M | Buy |
120,771
+69,340
| +135% | +$2.47M | 0.59% | 28 |
|
|
2015
Q3 | $1.7M | Sell |
51,431
-100,421
| -66% | -$3.32M | 0.04% | 520 |
|
|
2015
Q2 | $6.36M | Buy |
+151,852
| New | +$6.36M | 0.17% | 143 |
|